Neutrogena Ageless Intensives Tone Correcting Tinted Daily Moisturizer SPF 30 Helioplex

Dosage form: lotion
Ingredients: Avobenzone 30mg in 1mL, Homosalate 40mg in 1mL, Octisalate 50mg in 1mL, Octocrylene 50mg in 1mL, Oxybenzone 50mg in 1mL
Labeler: Neutrogena Corporation
NDC Code: 10812-413

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Neutrogena Ageless Intensives Tone Correcting Tinted Daily Moisturizer SPF 30

Directions

Apply evenly to cleansed face and neck daily, reapplying as needed. To maintain formula efficacy, turn pump to "closed" position (left) after every use. Can be used under or in place of make-up. For great results, use with tone Correcting Targeting treatment.

Important

You may experience mild redness, a warm tingling sensation or flaking (skin exfoliation). These are normal, temporary indications that the formula is working. If effects persist or cause discomfort, limit use to once every other day until your skin adjusts, then revert back to daily use.

Warnings

For external use only. Avoid contact with eyes. If contact occurs, flush thoroughly with water.

Discontinue use if irritation or rash appear.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.

Questions or comments?

1-800-299-4786 or www.neutrogena.com

Active Ingredients

Avobenzone 3%, Homosalate 4%, Octisalate 5%, Octocrylene 5%, Oxybenzone 5%

Inactive Ingredients

Water, PPG-15 Stearyl Ether, Cyclopentasiloxane, Glycerin, Silica, Isohexxadecane, Polyamide-5, Ascorbyl Glucoside, Titanium Dioxxide, Lauroyl Lysine, Niacinamide, Pentylene Glycol, Tocopheryl Acetate, BHT, Ascorbic Acid, Cetyl Alcohol, Bisabolol, Caprylyl Glycol, Butylene Glycol, Glyceryl Stearate, Hydroxypenyl Propamidobenzoic Acid, Retinol, Polysorbate 20, Styrene/Acrylates Copolymer, Dimethicone, PEG-75 Stearate, Trisiloxane, Cyclohexasiloxane, PEG-8, Dimethicone Crosspolymer, Ammonium Acryloyldimethyltaurate/VP Copolymer, Potassium Cetyl Phosphate, Sodium Polyacrylate, Laureth-23, Laureth-4, Dipotassium Glycyrrhizate, Ceteth-20, Steareth-20, Sodium Hydroxide, Citric Acid, Disodium EDTA, Mica, Iron Oxides, Fragrance

PRINCIPAL DISPLAY PANEL - 29 mL Bottle Carton

AGELESS INTENSIVES™

NEW

Tone Correcting
Tinted Moisture

helioplex
SPF 30

instant
radiance

RETINOL|SA
A concentrated treatment with
Retinol SA and Stabilized Vitamin C

Neutrogena®

DERMATOLOGIST RECOMMENDED

1 FL OZ (29mL)

NEUTROGENA AGELESS INTENSIVES TONE CORRECTING TINTED DAILY MOISTURIZER   SPF 30 HELIOPLEX
avobenzone, homosalate, octisalate, octocrylene, and oxybenzone lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:10812-413
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Avobenzone (Avobenzone) Avobenzone30 mg  in 1 mL
Homosalate (Homosalate) Homosalate40 mg  in 1 mL
Octisalate (Octisalate) Octisalate50 mg  in 1 mL
Octocrylene (Octocrylene) Octocrylene50 mg  in 1 mL
Oxybenzone (Oxybenzone) Oxybenzone50 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
Water 
Cyclomethicone 5 
Glycerin 
Silicon Dioxide 
Isohexadecane 
Titanium Dioxide 
Lauroyl Lysine 
Niacinamide 
Pentylene Glycol 
.ALPHA.-TOCOPHEROL ACETATE 
BUTYLATED HYDROXYTOLUENE 
Ascorbic Acid 
Cetyl Alcohol 
Levomenol 
Caprylyl Glycol 
Butylene Glycol 
Glyceryl Monostearate 
Retinol 
Polysorbate 20 
Dimethicone 
Cyclomethicone 6 
POLYETHYLENE GLYCOL 400 
Potassium Cetyl Phosphate 
Laureth-23 
Laureth-4 
Ceteth-20 
Steareth-20 
Sodium Hydroxide 
Citric Acid Monohydrate 
Edetate Disodium 
Mica 
Packaging
#Item CodePackage Description
1NDC:10812-413-011 BOTTLE, PUMP in 1 CARTON
129 mL in 1 BOTTLE, PUMP
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart35212/01/201001/02/2015
Labeler - Neutrogena Corporation (008254617)

Revised: 03/2013
 
Neutrogena Corporation

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web1)